XML 21 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 3 - Basis of Presentation and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
3.
Basis of Presentation and Summary of Significant Accounting Policies
 
The Summary of Significant Accounting Policies included in the Company's Form
10
-K for the year ended
December 31, 2016,
filed with the Securities and Exchange Commission on
March 31, 2017
have
not
materially changed, except as set forth below.
 
Basis of Presentation
 
The accompanying unaudited interim
 condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information as found in the Accounting Standard Codification (“ASC”) and Accounting Standards Updates (“ASUs”) of the Financial Accounting Standards Board (“FASB”), and with the instructions to Form
10
-Q and Article
10
of Regulation S-
X
of the Securities and Exchange Commission (the “SEC”). In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements of the Company include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company’s financial position as of 
September 
30,
2017,
its results of operations for the
three
and
nine
months ended
September 
30,
2017
and
2016
and cash flows for the
nine
months ended
September 
30,
2017
and
2016.
Operating results for the
nine
months ended 
September 
30,
2017
are
not
necessarily indicative of the results that
may
be expected for the year ending
December 
31,
2017.
The unaudited interim condensed consolidated financial statements presented herein do
not
contain the required disclosures under GAAP for annual financial statements. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the annual audited financial statements and related notes as of and for the year ended
December 
31,
2016
filed with the SEC on Form
10
-K on
March 31, 2017.
 
Use of Estimates
 
The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date the financial statements and reported amounts of expense during the reporting period. Actual results could differ from those estimates. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the unaudited condensed consolidated financial statements, actual results
may
materially vary from these estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited interim condensed consolidated financial statements in the period they are deemed necessary.
 
Cash and Cash Equivalents and Certificate of Deposit
 
The Company considers any highly liquid investments, such as money market funds, with an original maturity of
three
months or less to be cash and cash equivalents. The Company's certificate of deposit has a maturity greater than
three
months but within
one
year of the date of purchase. This certificate of deposit is classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost.
 
Fair Value of Financial Instruments
 
The carrying amounts of the Company
’s financial instruments, including cash equivalents, certificate of deposit, accounts payable, and accrued expenses approximate fair value due to the short-term nature of those instruments. As of
September 
30,
2017,
the fair value of the Company's outstanding Series B convertible note was approximately
$0.5
million. As of
December 
31,
2016,
the fair value of the Company’s outstanding
2016
convertible note and Series B convertible note was approximately
$2.0
million and
$0.6
million, respectively. The
2016
convertible note was paid in full during the
three
month period ended
September 30, 2017.
The fair value of the convertible notes is determined using a binomial lattice model that utilizes certain unobservable inputs that fall within Level
3
of the fair value hierarchy.
 
Offering Costs
 
Offering costs are either expensed upon completion or abandonment of the related financing or offset against the proceeds of the offering, depending upon the accounting treatment of the offering. Offering costs consist principally of legal costs incurred through the balance sheet date related to the Company
’s private placement financings and are recognized in other assets on the consolidated balance sheet. During the
three
months ended
September 
30,
2017,
management decided to
not
move forward with the Series B financing, which was originally contemplated and disclosed in the Company's definitive proxy statement filed with the Securities and Exchange Commission on
May 1, 2017,
and expensed
$98,000
of previously capitalized offering costs related to the financing.
 
Intangible Assets and Goodwill
 
In connection with the Merger, the Company acquired indefinite-lived In-Process Research and Development Assets (“IPR&D”) RES-
529
and RES-
440,
with estimated fair values of
$8.6
million and
$1.0
million, respectively, and recognized
$6.9
million in goodwill. In the
third
quarter of
2016,
the IPR&D asset associated with RES-
440
was abandoned and written down to
$0.
RES-
529
and goodwill are assessed for impairment on each of
October 1
of the Company
’s fiscal year or more frequently if impairment indicators exist. The Company has a single reporting unit and all goodwill relates to that reporting unit. There were
no
impairment indicators or impairments to RES-
529
or goodwill during the
three
and
nine
months ended
September 30, 2017.
 
Net Income (Loss) Per Common Share
 
For the
three
and
nine
months ended
September 30, 2017,
the Company used the
two
-class method to compute basic net income per common share because the Company has issued securities ("Series A convertible preferred stock") that entitle the holder to participate in dividends and earnings of the Company. Under this method, net income is reduced by any dividends earned during the period. The remaining earnings ("undistributed earnings") are allocated to common stock and the Series A convertible preferred stock to the extent that the Series A convertible preferred stock
may
share in earnings. In periods of net loss, losses are
not
allocated to participating securities as the holders of such securities have
no
 obligation to fund losses. The total earnings allocated to common stock is then divided by the weighted average common shares outstanding to determine the basic earnings per share. 
 
For purposes of calculating diluted loss per common share, the denominator includes both the weighted average common shares outstanding and the number of common stock equivalents if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include stock options, unvested restricted stock awards and warrants using the treasury stock method. The Company considers the potential dilutive impact of its convertible debt instruments using the "if-converted" method. In addition, the Company considers the potential dilutive impact of its convertible preferred shares using the “if-converted” method if more dilutive than the
two
-class method. For convertible preferred shares, the
two
-class method was more dilutive than the “if-converted” method for the
three
months ended
September 30, 2017.
 
The following table sets forth the computation of basic and diluted earnings per share:
 
   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2017
   
2016
   
2017
   
2016
 
Basic net income (loss) per common share calculation:
                               
Net income (loss)
  $
5,096,856
    $
(5,436,553
)
  $
(3,154,181
)
  $
(15,465,912
)
Accretion of Series A cumulative preferred dividends
   
(366,641
)
   
     
(912,946
)
   
 
Undistributed earnings to participating securities
   
(1,838,354
)
   
     
     
 
Net income (loss) attributable to common stockholders
  $
2,891,861
    $
(5,436,553
)
  $
(4,067,127
)
  $
(15,465,912
)
                                 
Weighted average shares outstanding, basic
   
13,937,869
     
10,333,898
     
11,709,128
     
10,198,491
 
Net income (loss) per share of common, basic
  $
0.21
    $
(0.53
)
  $
(0.35
)
  $
(1.52
)
                                 
Diluted net income (loss) per common share calculation:
                               
Net income (loss) attributable to common stockholders
   
2,891,861
     
(5,436,553
)
   
(4,067,127
)
   
(15,465,912
)
Change in fair value of warrant liability
   
     
     
(18,909,792
)
   
 
 
Interest on convertible debt
   
28,891
     
     
     
 
Diluted net loss
   
2,920,752
     
(5,436,553
)
   
(22,976,919
)
   
(15,465,912
)
Weighted average common shares outstanding, basic
   
13,937,869
     
10,333,898
     
11,709,128
     
10,198,491
 
Common stock equivalents arising from stock options
   
20,608
     
     
     
 
Common stock equivalents arising from warrants
   
     
     
816,579
     
 
Common stock equivalents arising from convertible debt
   
756,376
     
     
     
 
Common stock equivalents
   
14,714,853
     
10,333,898
     
12,525,707
     
10,198,491
 
Net income (loss) per share of common stock, diluted
  $
0.20
    $
(0.53
)
  $
(1.83
)
  $
(1.52
)
 
The following potentially dilutive securities outstanding as of
September 
30,
2017
and
2016
have been excluded from the computation of diluted weighted average shares outstanding, as they would be anti-dilutive:
 
   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2017
   
2016
   
2017
   
2016
 
Convertible debt
   
     
749,280
     
213,879
     
749,280
 
Common stock warrants
   
14,003,608
     
460,721
     
447,721
     
460,721
 
Stock options
   
2,521,605
     
2,010,409
     
2,545,989
     
2,010,409
 
Unvested restricted stock awards
   
4,599
     
10,738
     
4,599
     
10,738
 
     
16,529,812
     
3,231,148
     
3,212,188
     
3,231,148
 
 
Amounts in the table reflect the common stock equivalents of the noted instruments.
 
 
Recent Accounting Pronouncements
 
In
July
 
2017,
the FASB issued ASU
2017
-
11,
Earnings Per Share (Topic
260
); Distinguishing Liabilities from Equity (Topic
480
); Derivatives and Hedging (Topic
815
): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.
The
first
part of this update addresses the complexity of accounting for certain financial instruments with down round features and the
second
part addresses the complexity of distinguishing liabilities from equity. The guidance is applicable to public business entities for fiscal years beginning after
December 15, 2018
and interim periods within those years. The Company is currently evaluating the potential impact of the adoption of this standard on its consolidated results of operations, financial position and cash flows and related disclosures.
 
In
May 2017,
the FASB issued ASU
No.
2017
-
09,
Modification Accounting for Share-Based Payment Arrangements
, which amends the scope of modification accounting for share-based payment arrangements. The ASU provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC
718.
Specifically, an entity would
not
apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. The guidance is applicable to public business entities for fiscal years beginning after
December 15, 2017
and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company does
not
expect this new guidance to have a material impact on its condensed consolidated financial statements.
 
In
March
 
2016,
the FASB issued ASU
2016
-
09,
Compensation – Improvements to Employee Share-Based Payment Accounting
, which simplifies several aspects of the accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The guidance is applicable to public business entities for fiscal years beginning after
December 15, 2016
and interim periods within those years. The Company adopted this standard in
2017
by electing to account for forfeitures in the period that they occur. Under ASU
2016
-
09,
accounting changes adopted using the modified retrospective method must be calculated as of the beginning of the period adopted and reported as a cumulative-effect adjustment. As a result, the Company recognized cumulative-effect adjustment of approximately
$1,000
on
January 1, 2017.
 
In
February 2016,
the FASB issued ASU
2016
-
02,
Leases (Topic
842
)
. The FASB issued the update to require the recognition of lease assets and liabilities on the balance sheet of lessees. The standard will be effective for fiscal years beginning after
December 
15,
2018,
including interim periods within such fiscal years. The ASU requires a modified retrospective transition method with the option to elect a package of practical expedients. Early adoption is permitted. The Company is currently evaluating the potential impact of the adoption of this standard on its consolidated results of operations, financial position and cash flows and related disclosures.